Event Videos

https://pubmed.ncbi.nlm.nih.gov/38397305/ Hepatoblastoma
Children (Basel). 2024 Feb 3;11(2):193.
doi: 10.3390/children11020193.

Risk for Recurrence in Long-Term Follow-Up of Children after Liver Transplantation for Hepatoblastoma or Hepatocellular Carcinoma

Marek Stefanowicz 1, Piotr Kaliciński 1, Hor Ismail 1, Adam Kowalski 1, Dorota Broniszczak 1, Marek Szymczak 1, Katarzyna Pankowska-Woźniak 1, Anna Roszkiewicz 1, Ewa Święszkowska 2, Diana Kamińska 3, Sylwia Szymańska 4, Grzegorz Kowalewski 1

Abstract

Published on: 
Feb-2024

https://pubmed.ncbi.nlm.nih.gov/38376650/ hepatitis b
Hepatol Int. 2024 Feb 20.
doi: 10.1007/s12072-023-10631-9. Online ahead of print.

Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B

Min Zhang # 1, Jing Li # 2, Zhiqiang Xu 1, Peiyao Fan 3, Yi Dong 1, Fuchuan Wang 1, Yinjie Gao 1, Jianguo Yan 1, Lili Cao 1, Dong Ji 1, Danni Feng 1, Yanwei Zhong 1, Yang Zhang 2, Weiguo Hong 2, Chao Zhang 2, Fu-Sheng Wang 4 5

Abstract

Published on: 
Feb-2024

https://pubmed.ncbi.nlm.nih.gov/38418429/ NAFLD

J Gastroenterol Hepatol. 2024 Feb 28.
doi: 10.1111/jgh.16521. Online ahead of print.

PARVB and HSD17B13 variants are associated with nonalcoholic fatty liver disease in children

Kyung Jae Lee 1 2, Jin Soo Moon 1, Jin Gyu Lim 1, Homin Huh 1, Jeong Eun Ahn 1, Lia Kim 1, Nan Young Kim 3, Jae Sung Ko 1

Abstract

Background and aim: The aim of this study was to investigate the comprehensive genetic effects of exploratory variants of LYPLAL1, GCKR, HSD17B13, TRIB1, APOC3, MBOAT7, and PARVB on pediatric nonalcoholic fatty liver disease in addition to the previously reported variants of TM6SF2, PNPLA3, and SAMM50 in Korean children.

Published on: 
Feb-2024

https://pubmed.ncbi.nlm.nih.gov/38374561/ liver transplant
Multicenter Study

J Pediatr Gastroenterol Nutr. 2024 Feb;78(2):328-338.
doi: 10.1002/jpn3.12112. Epub 2024 Jan 2.

Impact of early immunosuppression on pediatric liver transplant outcomes within 1 year

Vikram K Raghu 1, Xingyu Zhang 2, James E Squires 1, Elizabeth Eisenberg 3, Amy G Feldman 4, Jennifer Halma 5, Anna L Peters 6 7, Regino P Gonzalez-Peralta 8, Vicky L Ng 9, Simon P Horslen 1, Steven J Lobritto 10, John Bucuvalas 11, George V Mazariegos 2, Emily R Perito 12

Abstract

Published on: 
Feb-2024

https://pubmed.ncbi.nlm.nih.gov/38378358/ biliary atresia
Arab J Gastroenterol. 2024 Feb 19:S1687-1979(24)00015-7.
doi: 10.1016/j.ajg.2024.01.015.Online ahead of print.

Effect of medium chain triglycerides enriched formula on growth of biliary atresia patients after Kasai portoenterostomy

Nehal El-Koofy 1, Eman Mahmoud 1, Fatma El Mougy 2, Engy Nasr 3, Sawsan Okasha 1, Hanaa El-Karaksy 1, Ghada Anwar 1, Mortada H El-Shabrawi 4, Nora E Badawi 1, Noha Arafa 5

Abstract

Published on: 
Feb-2024

https://pubmed.ncbi.nlm.nih.gov/38374552/ Liver transplant

Randomized Controlled Trial

J Pediatr Gastroenterol Nutr. 2024 Feb;78(2):350-359.
doi: 10.1002/jpn3.12077. Epub 2023 Dec 11.

Midodrine reduces new-onset acute kidney injury and hyponatremia in children with cirrhosis and ascites awaiting liver transplantation: Results from an open-label RCT

A Ashritha 1, Bikrant B Lal 1, Rajeev Khanna 1, Vikrant Sood 1, Arun K Sood 1, Seema Alam 1

Abstract

Published on: 
Feb-2024

https://pubmed.ncbi.nlm.nih.gov/38388968/ NAFLD

World J Pediatr. 2024 Feb 22.
doi: 10.1007/s12519-023-00789-5. Online ahead of print.

Continuous age- and sex-specific reference ranges of liver enzymes in Chinese children and application in pediatric non-alcoholic fatty liver disease

Zhao-Yuan Wu 1, Si-Wei Chi 1, Liu-Jian Ouyang 1, Xiao-Qin Xu 1, Jing-Nan Chen 1, Bing-Han Jin 1, Rahim Ullah 1, Xue-Lian Zhou 1, Ke Huang 1, Guan-Ping Dong 1, Zhe-Ming Li 2, Ying Shen 3, Jie Shao 3, Yan Ni 1, Jun-Fen Fu 4, Qiang Shu 5, Wei Wu 6

Abstract

Published on: 
Feb-2024

https://pubmed.ncbi.nlm.nih.gov/38374548/ acute liver failure
J Pediatr Gastroenterol Nutr. 2024 Feb;78(2):320-327.
doi: 10.1002/jpn3.12094.Epub 2023 Dec 12.

Improved mortality prediction for pediatric acute liver failure using dynamic prediction strategy

Ruosha Li 1, Jingyan Wang 1, Cuihong Zhang 1, James E Squires 2, Steven H Belle 3, Jing Ning 4, Jianwen Cai 5, Robert H Squires 2

Abstract
Objectives: To develop and validate a prediction tool for pediatric acute liver failure (PALF) mortality risks that captures the rapid and heterogeneous clinical course for accurate and updated prediction.

Published on: 
Feb-2024

https://pubmed.ncbi.nlm.nih.gov/38390691/ NAFLD
J Pediatr Gastroenterol Nutr. 2024 Feb 23.
doi: 10.1002/jpn3.12163. Online ahead of print.

A serum-induced gene signature in hepatocytes is associated with pediatric nonalcoholic fatty liver disease

T Hang Nghiem-Rao 1, Jethro S Johnson 2 3, Amy Pan 4 5, Samantha N Atkinson 5 6, Cynthia Behling 7 8, Pippa M Simpson 4, Mary L Holtz 5 9, George M Weinstock 2 10, Jeffrey B Schwimmer 7 11, Nita H Salzman 5 6 9

Abstract

Published on: 
Feb-2024

https://pubmed.ncbi.nlm.nih.gov/38369891/ hepatitis C

J Pediatr Gastroenterol Nutr. 2024 Feb 18.

doi: 10.1002/jpn3.12160. Online ahead of print.

ESPGHAN recommendations on treatment of chronic hepatitis C virus infection in adolescents and children including those living in resource-limited settings

Giuseppe Indolfi 1 2, Regino P Gonzalez-Peralta 3, Maureen M Jonas 4, Manal Hamdy-El Sayed 5, Björn Fischler 6, Etienne Sokal 7, Stefan Wirth 8, Emanuele Nicastro 9; Hepatology Committee of the ESPGHAN

Abstract

Published on: 
Feb-2024
1 2 3 4 5 6 7 8 9 next › last »

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: